Becton, Dickinson & Co. (BDX)

• Annual Data
• Quarterly Data

Becton, Dickinson & Co., Common-Size Consolidated Income Statement

	12 months ended	Sep 30, 2018		Sep 30, 2017		Sep 30, 2016		Sep 30, 2015		Sep 30, 2014		Sep 30, 2013
	Revenues
	Cost of products sold
	Gross profit
	Selling and administrative expense
	Research and development expense
	Acquisitions and other restructurings
	Other operating expense, net
	Operating income
	Interest expense
	Interest income
	Losses on debt extinguishment
	Vyaire Medical-related amounts
	Other equity investment income
	Losses on undesignated foreign exchange derivatives, net
	Royalty income
	Gains on previously held investments
	Other
	Other income (expense), net
	Income from continuing operations before income taxes
	Income tax (provision) benefit
	Income from continuing operations
	Income from discontinued operations, net of income tax provision
	Net income
	Preferred stock dividends
	Net income applicable to common shareholders

Based on: 10-K (filing date: 2018-11-21), 10-K (filing date: 2017-11-22), 10-K (filing date: 2016-11-23), 10-K (filing date: 2015-11-25), 10-K (filing date: 2014-11-26), 10-K (filing date: 2013-11-27).